Keywords: Multiple Sclerosis, Hyperpolarized MR (Non-Gas)We used hyperpolarized 13C MR spectroscopy imaging (MRSI) in a multiple sclerosis model and showed that we could monitor immune cell activation by measuring hyperpolarized [1-13C]pyruvate conversion to lactate. We further demonstrated that this approach detected response to two existing treatments, fingolimod and dimethyl fumarate. We observed a reduction of pyruvate-to-lactate flux after treatment, that can be explained by increased pyruvate dehydrogenase activity and decrease of immune cells. In addition, we evaluated brain perfusion using hyperpolarized [13C]urea, but saw no therapy effect. Altogether, we demonstrated that hyperpolarized 13C MRSI has potential to monitor immunomodulatory therapies within the central nervous system.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords